Home > Faculty > Minneapolis VAMC > Morrison, Vicki
Morrison, Vicki
 Vicki A. Morrison, M.D. is an Associate Professor of Medicine in the Sections of Hematology/Oncology and Infectious Disease. Dr. Morrison received her infectious disease training at the National Naval Medical Center (Bethesda, MD), followed by Medical Oncology training at the University of Minnesota Hospital. Her current clinical research interests include: 1) infectious complications of oncology patients, to include a) infectious complications of patients treated with nucleoside analogues, b) mucosal immune function in patients with CLL and multiple myeloma, c) neutropenic prophylaxis in patients receiving cyclical myelosuppressive therapy, d) therapeutic protocols utilizing echinocandins for fungal infections, and e) fungal infections in bone marrow transplant patients; 2) transplant-related lymphoproliferative disorders (evaluation, therapy), 3) therapy of intermediate-grade non-Hodgkin's lymphoma in the elderly, and 4) therapy and complications of chronic lymphocytic leukemia.
Selected Publications:
Morrison VA, Picozzi V, Scott S, Pohlman B, Dickman E, Lee M, Lawless G, Kerr R, Caggiano V, Delgado D, Fridman M, Ford J, Carter WB. The impact of age on delivered dose intensity and hospitalizations for febrile neutropenia in patients with intermediate grade non-Hodgkins lymphoma receiving initial CHOP chemotherapy: A risk factor analysis. Clin Lymphoma 2001; 2:47-56.
Morrison VA. Update on prophylaxis and therapy of infection in patients with chronic lymphocytic leukemia. Expert Review of Anticancer Therapy 2001; 1:84-90.
Morrison VA, Rai KR, Peterson B, Kolitz JE, Elias L., Appelbaum FR, Hines JD, Shepherd L, Martell R, Larson RA, Schiffer CA. The impact of therapy with Chlorambucil, fludarabine, or fludabarine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: An intergroup study (CALGB 9011). J Clin Oncol 2001; 19:3611-3621.
Morrison VA, Rai KR, Peterson B, Kolitz JE, Elias L, Appelbaum FR, Hines JD, Shepherd L, Larson RA, Schiffer CA: Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: Results of an intergroup study (CALGB 9011). J Clin Oncol 2002; 20:3878-3884.
Perfect JR, Cox GM, Lee JY, Kauffman CA, De Repentigny L, Chapman SM, Morrison VA, Pappas P, Heimenz JW, Stevens DA. The impact of culture isolation of Aspergillus: A hospital-based survey of aspergillosis: Mycoses Study Group Study #35. Clin Infect Dis 2001; 33:1824-1833
|
Return to: Department of Medicine : Medical School : Academic Health Center : myU : U of M Home
